Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
1 Belgrade School of Medicine, Bezanijska Kosa University Medical Center, Division of Endocrinology, Diabetes and Metabolic disorders, University of Belgrade, Belgrade, Serbia.
2 Belgrade School of Medicine, "Zvezdara" University Medical Center, Division of Endocrinology, Diabetes and Metabolic disorders, University of Belgrade, Belgrade, Serbia. dorabeljic@beotel.net.
3 Clinic for Endocrinology, Faculty of Medicine, University of Nis, Nis, Serbia.
In the original publication, values of the doses of insulin glargine, the most commonly used basal insulin analogue under the 'Discussion' section was incorrectly published.